Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP) - 02/09/11
Abstract |
Photochemotherapy with psoralens and UVA (PUVA) is widely used in the treatment of psoriasis and many other skin conditions. Cutaneous adverse reactions to 8-methoxypsoralen (8-MOP) appear to be rare and may be difficult to distinguish from phototoxicity or UV-induced polymorphic light eruption. We describe a patient who had a systemic allergic contact dermatitis to 8-MOP develop during her second course of PUVA treatment for psoriasis. (J Am Acad Dermatol 2001;45:S218-9.)
Le texte complet de cet article est disponible en PDF.Plan
This supplement is made possible through an unrestricted educational grant from Stiefel Laboratories to the American Academy of Dermatology. |
|
Reprint requests: Jane Ravenscroft, MBChB MRCP, Department of Dermatology, Queens Medical Centre, Clifton Boulevard, Nottingham, N97 2UH, England. E-mail: ravo@compuserve.com. |
Vol 45 - N° 6S
P. S218-S219 - décembre 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?